Logo image of HSHP.OL

HIMALAYA SHIPPING LTD (HSHP.OL) Stock Fundamental Analysis

Europe - OSL:HSHP - BMG4660A1036 - Common Stock

85 NOK
+2.7 (+3.28%)
Last: 9/12/2025, 7:00:00 PM
Fundamental Rating

2

HSHP gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 18 industry peers in the Marine Transportation industry. HSHP may be in some trouble as it scores bad on both profitability and health. HSHP has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year HSHP was profitable.
HSHP had a positive operating cash flow in the past year.
HSHP.OL Yearly Net Income VS EBIT VS OCF VS FCFHSHP.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -100M -200M -300M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.74%, HSHP is doing worse than 88.89% of the companies in the same industry.
HSHP has a Return On Equity of 4.03%. This is amonst the worse of the industry: HSHP underperforms 88.89% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.32%, HSHP is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA 0.74%
ROE 4.03%
ROIC 5.32%
ROA(3y)0.51%
ROA(5y)N/A
ROE(3y)4.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HSHP.OL Yearly ROA, ROE, ROICHSHP.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 5 10

1.3 Margins

HSHP has a Profit Margin of 5.32%. This is in the lower half of the industry: HSHP underperforms 77.78% of its industry peers.
Looking at the Operating Margin, with a value of 47.90%, HSHP belongs to the top of the industry, outperforming 94.44% of the companies in the same industry.
HSHP has a better Gross Margin (76.12%) than 94.44% of its industry peers.
Industry RankSector Rank
OM 47.9%
PM (TTM) 5.32%
GM 76.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
HSHP.OL Yearly Profit, Operating, Gross MarginsHSHP.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 20 40 60

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HSHP is destroying value.
HSHP has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, HSHP has a worse debt to assets ratio.
HSHP.OL Yearly Shares OutstandingHSHP.OL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M
HSHP.OL Yearly Total Debt VS Total AssetsHSHP.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

HSHP has an Altman-Z score of 0.83. This is a bad value and indicates that HSHP is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of HSHP (0.83) is worse than 72.22% of its industry peers.
The Debt to FCF ratio of HSHP is 19.60, which is on the high side as it means it would take HSHP, 19.60 years of fcf income to pay off all of its debts.
HSHP has a Debt to FCF ratio of 19.60. This is in the lower half of the industry: HSHP underperforms 77.78% of its industry peers.
A Debt/Equity ratio of 4.25 is on the high side and indicates that HSHP has dependencies on debt financing.
With a Debt to Equity ratio value of 4.25, HSHP is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.25
Debt/FCF 19.6
Altman-Z 0.83
ROIC/WACC0.64
WACC8.28%
HSHP.OL Yearly LT Debt VS Equity VS FCFHSHP.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

2.3 Liquidity

HSHP has a Current Ratio of 0.95. This is a bad value and indicates that HSHP is not financially healthy enough and could expect problems in meeting its short term obligations.
HSHP's Current ratio of 0.95 is on the low side compared to the rest of the industry. HSHP is outperformed by 61.11% of its industry peers.
HSHP has a Quick Ratio of 0.95. This is a bad value and indicates that HSHP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of HSHP (0.90) is worse than 61.11% of its industry peers.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.9
HSHP.OL Yearly Current Assets VS Current LiabilitesHSHP.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 10M 20M 30M

4

3. Growth

3.1 Past

The earnings per share for HSHP have decreased strongly by -50.00% in the last year.
HSHP shows a strong growth in Revenue. In the last year, the Revenue has grown by 44.78%.
EPS 1Y (TTM)-50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.5%
Revenue 1Y (TTM)44.78%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.17%

3.2 Future

Based on estimates for the next years, HSHP will show a very strong growth in Earnings Per Share. The EPS will grow by 49.11% on average per year.
Based on estimates for the next years, HSHP will show a quite strong growth in Revenue. The Revenue will grow by 12.15% on average per year.
EPS Next Y2.61%
EPS Next 2Y66.02%
EPS Next 3Y49.11%
EPS Next 5YN/A
Revenue Next Year3.42%
Revenue Next 2Y14.61%
Revenue Next 3Y12.15%
Revenue Next 5YN/A

3.3 Evolution

HSHP.OL Yearly Revenue VS EstimatesHSHP.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 50M 100M 150M
HSHP.OL Yearly EPS VS EstimatesHSHP.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 61.59, HSHP can be considered very expensive at the moment.
Based on the Price/Earnings ratio, HSHP is valued expensively inside the industry as 88.89% of the companies are valued cheaper.
HSHP's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.30.
A Price/Forward Earnings ratio of 6.50 indicates a rather cheap valuation of HSHP.
61.11% of the companies in the same industry are more expensive than HSHP, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.73. HSHP is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 61.59
Fwd PE 6.5
HSHP.OL Price Earnings VS Forward Price EarningsHSHP.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HSHP is valued a bit more expensive than the industry average as 77.78% of the companies are valued more cheaply.
HSHP's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 11.18
EV/EBITDA 12.38
HSHP.OL Per share dataHSHP.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HSHP does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as HSHP's earnings are expected to grow with 49.11% in the coming years.
PEG (NY)23.62
PEG (5Y)N/A
EPS Next 2Y66.02%
EPS Next 3Y49.11%

0

5. Dividend

5.1 Amount

HSHP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HIMALAYA SHIPPING LTD

OSL:HSHP (9/12/2025, 7:00:00 PM)

85

+2.7 (+3.28%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryMarine Transportation
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners19.04%
Inst Owner ChangeN/A
Ins Owners0.88%
Ins Owner ChangeN/A
Market Cap3.96B
Analysts81.67
Price Target87.21 (2.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend4.65
Dividend Growth(5Y)N/A
DP310.27%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-29.02%
Min EPS beat(2)-84.52%
Max EPS beat(2)26.47%
EPS beat(4)1
Avg EPS beat(4)-39.42%
Min EPS beat(4)-84.52%
Max EPS beat(4)26.47%
EPS beat(8)1
Avg EPS beat(8)-54.73%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.65%
Min Revenue beat(2)-10.65%
Max Revenue beat(2)9.35%
Revenue beat(4)1
Avg Revenue beat(4)-2.54%
Min Revenue beat(4)-10.65%
Max Revenue beat(4)9.35%
Revenue beat(8)2
Avg Revenue beat(8)-3.09%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)13.1%
PT rev (3m)3.74%
EPS NQ rev (1m)-3.23%
EPS NQ rev (3m)N/A
EPS NY rev (1m)-14.16%
EPS NY rev (3m)-59.82%
Revenue NQ rev (1m)-0.33%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.13%
Revenue NY rev (3m)-12.13%
Valuation
Industry RankSector Rank
PE 61.59
Fwd PE 6.5
P/S 3.32
P/FCF 11.18
P/OCF 11.24
P/B 2.51
P/tB 2.51
EV/EBITDA 12.38
EPS(TTM)1.38
EY1.62%
EPS(NY)13.08
Fwd EY15.39%
FCF(TTM)7.6
FCFY8.94%
OCF(TTM)7.57
OCFY8.9%
SpS25.63
BVpS33.83
TBVpS33.83
PEG (NY)23.62
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.74%
ROE 4.03%
ROCE 6.91%
ROIC 5.32%
ROICexc 5.48%
ROICexgc 5.48%
OM 47.9%
PM (TTM) 5.32%
GM 76.12%
FCFM 29.66%
ROA(3y)0.51%
ROA(5y)N/A
ROE(3y)4.12%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 4.25
Debt/FCF 19.6
Debt/EBITDA 7.79
Cap/Depr 0.57%
Cap/Sales 0.14%
Interest Coverage 1.13
Cash Conversion 40.96%
Profit Quality 557.88%
Current Ratio 0.95
Quick Ratio 0.9
Altman-Z 0.83
F-Score7
WACC8.28%
ROIC/WACC0.64
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-87.5%
EPS Next Y2.61%
EPS Next 2Y66.02%
EPS Next 3Y49.11%
EPS Next 5YN/A
Revenue 1Y (TTM)44.78%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.17%
Revenue Next Year3.42%
Revenue Next 2Y14.61%
Revenue Next 3Y12.15%
Revenue Next 5YN/A
EBIT growth 1Y38.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year45.13%
EBIT Next 3Y34.21%
EBIT Next 5YN/A
FCF growth 1Y110.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1062.73%
OCF growth 3YN/A
OCF growth 5YN/A